CM93, a novel covalent small molecule inhibitor targeting lung cancer with mutant EGFR
Q. Wang, J. Ni, T. Jiang…·J. Zhao
The paper develops CM93, a novel EGFR inhibitor with improved targeting and brain penetration, showing better efficacy and safety in mouse models of EGFR-mutant NSCLC and brain metastases.